Why do supplement ads get rejected on Meta even when they make no health claim?

Because the personal attribute rule is separate from the health claim rule. Copy that addresses the reader as someone with a deficiency, symptom or body concern implies you know something personal about them, and that is enough on its own. Rewrite the line so it describes who the product was formulated for instead of who is reading it.

Should I appeal a rejected supplement ad or rewrite it?

Rewrite it. An appeal is slow and, whichever way it goes, leaves you with no reusable pattern. A structural rewrite that moves the sentence from the reader to the product usually takes a minute and gives you a template for every future ad in the account.

How long should I wait before judging a supplement campaign?

Set the horizon from your own order data: take the median gap between first and second order among customers who bought twice, and use that as the evaluation window for the whole account. Keep a short-run guardrail on the first order so a genuinely broken campaign is not protected by a long window.

Does a subscription offer change the break-even calculation?

Yes, and usually in both directions. A first-box discount reduces the margin on the first order, so break-even must be recomputed from the discounted price, while the committed second order removes some of the uncertainty you were waiting on. Report subscribers and one-time buyers as separate cohorts so the two effects do not cancel each other out in one blended number.

Meta ads for supplement brands: the reorder math

Meta ads for supplement brands run into two problems that have nothing to do with bidding. The copy gets rejected before it serves, because the health and personal attribute rules cover more ground than most writers expect. And the campaign gets judged on a single purchase, when the product is a consumable that a satisfied customer buys again. Fix the first by writing to the policy in the first draft. Fix the second by deciding, before you launch, how long a cohort has to prove itself.

The two rules that decide whether Meta ads for supplement brands run

Meta's Advertising Standards restrict this category in two separate places, each catching a different mistake. Read the current policy text yourself before you brief a copywriter; a colleague's memory of what was allowed last year is not a safe reference.

Health claims. An ad may not present a supplement as something that treats, prevents or cures a condition, and may not promise a specific physical outcome. This is the rule everyone expects, and the easier of the two to write around, because the problem is visible in the sentence.

Personal attributes. An ad may not imply that you know something personal about the person reading it, including a health condition, a body concern or a medical history. This is the rule that surprises teams, because the offending copy often contains no claim at all. A line addressed directly to people with a particular deficiency, symptom or body shape is an assertion about the reader, and that is what the rule targets.

Rewrite the sentence instead of appealing the rejection

Appeals are slow and teach you nothing. A rewrite takes a minute and gives you a pattern you can reuse. The rewrites that work are structural, not cosmetic.

Move from the reader to the product. Rather than addressing a person who has a problem, describe who the formula was made for and what is in it. The information survives; the implication does not.
Drop the outcome and the deadline. Any sentence that names a result and a timeframe reads as a claim, whatever hedging follows it. Describe the format, the dose, the taste, the routine.
Cut body comparison imagery. Before and after visuals are the highest risk asset in this category. Pack shots, texture close-ups and routine footage carry the same message with far less exposure.
Do not lift wording from the pack. Text that is legal on Turkish packaging and cleared by your regulatory consultant is not automatically permitted in a Meta ad. The two review systems are unrelated; satisfy both.
Audit the landing page the same way. Review looks past the ad unit, so a clean ad pointing at a page of testimonials making medical claims is still a problem, and harder to diagnose, because the ad itself looks fine.

Some supplement categories carry additional restrictions, such as age gating or limits on available targeting options. Confirm which apply to your product type in Meta's official documentation rather than assuming one uniform rule governs the category.

A narrow message space makes rotation harder, not optional

Here is the second-order effect most brands miss. Once claims and reader-directed language are off the table, the number of distinct things you may say shrinks. A team with five permitted angles exhausts them faster than a team in an unrestricted category with twenty, and the instinctive response, nudging the claim a little further with each new ad, is precisely what puts the account at risk.

The way out is to rotate the container rather than the claim. One permitted proposition can be delivered as a founder explaining sourcing, an ingredient breakdown, a morning routine in a kitchen, an unboxing, a texture close-up, or a customer talking about convenience rather than results. Six assets, one compliant message. If you want the underlying mechanic, creative fatigue explains what you are fighting. The point here is that a restricted category needs a larger production plan than an unrestricted one just to stand still. Tooling built for creative optimization should be judged by whether it helps you produce and evaluate enough compliant variants, not by how clever one output looks.

Why first purchase ROAS gives the wrong verdict on a consumable

A supplement is bought, finished and bought again, yet the campaign that acquired the customer is judged on the first order alone. Here is that distortion in numbers you can check yourself.

Take one product at 600 lira with a 50% contribution margin, so 300 lira of margin per order. Break-even ROAS is 1 divided by 0.50, which is 2.00. Suppose you acquire 100 first-time customers at 450 lira each: 45,000 lira of spend, 60,000 lira of first-order revenue and 30,000 lira of margin. First-order ROAS is 60,000 divided by 45,000, which is 1.33, well under the 2.00 you need. On that figure alone you would switch the campaign off.

Now hold a 90-day window and suppose your own order history says 30 of those 100 customers place a second order inside it. That adds 18,000 lira of revenue and 9,000 lira of margin with no further acquisition cost. Over 90 days the cohort produces 78,000 lira of revenue and 39,000 lira of margin against 45,000 lira of spend, so the 90-day ROAS is 78,000 divided by 45,000, which is 1.73. Better, and still short of 2.00. The cohort is 6,000 lira down over 90 days, which is 60 lira per customer rather than the 150 lira per customer the first order implied.

That is the honest version, and more useful than a reassuring one. The reorder does not rescue the campaign by itself; it changes how far the other levers have to move. Solve 30,000 plus 300x equals 45,000 and you get x equals 50, so at this price, margin and acquisition cost you would need half of all first-time buyers to reorder within 90 days simply to break even. Two levers are usually easier to move. Reduce the 450 lira acquisition cost, or raise the first order: a three-unit bundle at 1,500 lira with the same 50% margin returns 750 lira of contribution, which clears 450 lira of cost on the first order alone, at a ROAS of 1,500 divided by 450, or 3.33. Run your own version through the break-even ROAS calculator before you argue with anyone about the target.

Designing the campaign around the reorder window

The window is an evaluation horizon, not a targeting setting. Three decisions follow from it.

Fix the horizon from your own data, once. Pull last year's customers who ordered twice and look at the gap between order one and two. Use the median, not the average: a handful of people who came back after a year will drag an average somewhere useless. Whatever number you get becomes the window for the whole account, and you hold it. Judging one campaign on 90 days and another on 30 leaves teams arguing about which is better while measuring different things.

Accept that the platform will not show you this. Attribution windows are counted in days and reorder gaps are counted in months, so the second order will almost never be credited to the ad that acquired the customer. The reorder view has to live in your own reporting, built from acquisition cohorts in your order data, with the platform figure as a short-run guardrail rather than a verdict. Since the second order is invisible, the first has to be efficient on its own terms, which makes reducing customer acquisition cost the lever with the fastest feedback loop.

Use the subscription offer to shorten the wait. A subscription converts an unknown future into a known one at acquisition, the only mechanic that lets you act quickly on a slow metric. It has a price: a first-box discount lowers first-order margin, so recompute break-even from the discounted figure, and keep subscribers and one-time buyers as separate cohorts from day one. Timing the retargeting that chases the second order is a separate exercise driven by the consumption cycle, not by campaign structure.

Where to start

If you are launching this week, read the current standards, rewrite every line that addresses the reader instead of the product, audit the landing page the same way, and pick an opening offer large enough that the first order stands on its own. If you are already running, pull the reorder gap from your order data, set one window, and rebuild the report around acquisition cohorts before deciding which campaigns are genuinely failing.